Neurokinin-1 Receptor Antagonists

Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS.

Also Known As:

Neurokinin-1 Receptor Blockers; Neuroleukin-1 Receptor Blockers; Substance P Receptor Antagonists; Substance P Receptor Blockers; Tachykinin Receptor 1 Antagonists; Tachykinin Receptor 1 Blockers; Antagonist, Neurokinin-1 Receptor; Antagonists, Neurokinin-1 Receptor; Blocker, Neurokinin-1 Receptor; Blocker, Neuroleukin-1 Receptor; Blockers, Neurokinin-1 Receptor; Blockers, Neuroleukin-1 Receptor; Neurokinin 1 Receptor Antagonists; Neurokinin 1 Receptor Blocker; Neurokinin 1 Receptor Blockers; Neuroleukin 1 Receptor Blocker; Neuroleukin 1 Receptor Blockers; Receptor Antagonist, Neurokinin-1; Receptor Antagonists, Neurokinin-1; Receptor Blocker, Neurokinin-1; Receptor Blocker, Neuroleukin-1; Receptor Blockers, Neurokinin-1; Receptor Blockers, Neuroleukin-1; Neurokinin 1 Receptor Antagonist; Neurokinin-1 Receptor Antagonist; Neurokinin-1 Receptor Blocker; Neuroleukin-1 Receptor Blocker; Substance P Receptor Antagonist; Substance P Receptor Blocker; Tachykinin Receptor 1 Antagonist; Tachykinin Receptor 1 Blocker

Chemical Actions and Uses
- Pharmacologic Actions: 164
  - Molecular Mechanisms of Pharmacological Action: 26
    - Neurotransmitter Agents: 13574
      - Neurokinin-1 Receptor Antagonists: 313
  - Physiological Effects of Drugs: 1
    - Neurotransmitter Agents: 13574
      - Neurokinin-1 Receptor Antagonists: 313

Ellenia Bordini Selected Research

Ellenia Bordini Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure